{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:33:27Z","timestamp":1777494807102,"version":"3.51.4"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.aohep.2020.04.012","type":"journal-article","created":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T11:19:34Z","timestamp":1591442374000},"page":"100212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"special_numbering":"C","title":["Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease"],"prefix":"10.1016","volume":"21","author":[{"given":"Guillermo Nah\u00fam","family":"L\u00f3pez-S\u00e1nchez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra","family":"D\u00f3minguez-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misael","family":"Uribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norberto Carlos","family":"Ch\u00e1vez-Tapia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalia","family":"Nu\u00f1o-L\u00e1mbarri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.aohep.2020.04.012_bib0420","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9895176","article-title":"Liver cholesterol overload aggravates obstructive cholestasis by inducing oxidative stress and premature death in mice","volume":"2016","author":"Nu\u00f1o-L\u00e1mbarri","year":"2016","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.aohep.2020.04.012_bib0425","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4254\/wjh.v9.i16.715","article-title":"Non-alcoholic fatty liver disease: an expanded review","volume":"9","author":"Benedict","year":"2017","journal-title":"World J Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0430","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.rgmx.2018.11.007","article-title":"Consenso mexicano de la enfermedad por h\u00edgado graso no alcoh\u00f3lico","volume":"84","author":"Bernal-Reyes","year":"2019","journal-title":"Rev Gastroenterol M\u00e9xico"},{"key":"10.1016\/j.aohep.2020.04.012_bib0435","first-page":"288","article-title":"Non-alcoholic fatty liver disease: controlling an emerging epidemic, challenges, and future directions","volume":"31","author":"Ofosu","year":"2018","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0440","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0445","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0450","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2147\/DMSO.S185705","article-title":"Progressive reduction in skeletal muscle mass to visceral fat area ratio is associated with a worsening of the hepatic conditions of non-alcoholic fatty liver disease","volume":"12","author":"Shida","year":"2019","journal-title":"Diabetes Metab Syndr Obes Targets Ther"},{"key":"10.1016\/j.aohep.2020.04.012_bib0455","doi-asserted-by":"crossref","DOI":"10.1210\/er.2019-00034","article-title":"The liver as an endocrine organ \u2013 linking NAFLD and insulin resistance","author":"Watt","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.aohep.2020.04.012_bib0460","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.beem.2016.06.006","article-title":"Non-alcoholic fatty liver disease and risk of type 2 diabetes","volume":"30","author":"Lallukka","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.aohep.2020.04.012_bib0465","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.metabol.2016.01.001","article-title":"Non-alcoholic fatty liver disease and diabetes","volume":"65","author":"Hazlehurst","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.04.012_bib0470","doi-asserted-by":"crossref","first-page":"774","DOI":"10.3390\/ijms17050774","article-title":"The natural course of non-alcoholic fatty liver disease","volume":"17","author":"Calzadilla Bertot","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0475","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0480","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7150\/ijbs.11039","article-title":"The effects of insulin pre-administration in mice exposed to ethanol: alleviating hepatic oxidative injury through anti-oxidative, anti-apoptotic activities and deteriorating hepatic steatosis through SRBEP-1c activation","volume":"11","author":"Liu","year":"2015","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0485","doi-asserted-by":"crossref","first-page":"11647","DOI":"10.1021\/acs.jafc.8b04116","article-title":"Ursolic acid, a novel liver X receptor \u03b1 (LXR\u03b1) antagonist inhibiting ligand-induced nonalcoholic fatty liver and drug-induced lipogenesis","volume":"66","author":"Lin","year":"2018","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.aohep.2020.04.012_bib0490","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2016.02.066","article-title":"Pathogenesis of nonalcoholic steatohepatitis","volume":"150","author":"MacHado","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0495","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.04.012_bib0500","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/hep.23312","article-title":"Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease","volume":"51","author":"Wong","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0505","doi-asserted-by":"crossref","first-page":"e14324","DOI":"10.1097\/MD.0000000000014324","article-title":"Association between PNPLA3 rs738409 polymorphism and nonalcoholic fatty liver disease (NAFLD) susceptibility and severity: a meta-analysis","volume":"98","author":"Dai","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aohep.2020.04.012_bib0510","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.aohep.2018.10.004","article-title":"Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population","volume":"18","author":"Mazo","year":"2019","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0515","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.3390\/nu6083303","article-title":"Epigenetic mechanisms underlying the link between non-alcoholic fatty liver diseases and nutrition","volume":"6","author":"Lee","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/j.aohep.2020.04.012_bib0520","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0525","doi-asserted-by":"crossref","first-page":"824","DOI":"10.7150\/ijms.8358","article-title":"Frequent co-expression of miRNA-5p and -3p species and cross-targeting in induced pluripotent stem cells","volume":"11","author":"Huang","year":"2014","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0530","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/nrm3838","article-title":"Regulation of microRNA biogenesis","volume":"15","author":"Ha","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0535","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12929-014-0095-x","article-title":"MicroRNA-5p and -3p co-expression and cross-targeting in colon cancer cells","volume":"21","author":"Choo","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0540","doi-asserted-by":"crossref","first-page":"21510","DOI":"10.1038\/srep21510","article-title":"Parallel expression profiling of hepatic and serum microRNA-122 associated with clinical features and treatment responses in chronic hepatitis C patients","volume":"6","author":"Butt","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2020.04.012_bib0545","doi-asserted-by":"crossref","first-page":"15079","DOI":"10.3748\/wjg.v20.i41.15079","article-title":"MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease","volume":"20","author":"Panera","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0550","doi-asserted-by":"crossref","first-page":"e1480","DOI":"10.1097\/MD.0000000000001480","article-title":"Epigenetic modifications in the biology of nonalcoholic fatty liver disease","volume":"94","author":"Pirola","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.aohep.2020.04.012_bib0555","doi-asserted-by":"crossref","first-page":"7223","DOI":"10.1093\/nar\/gkr254","article-title":"Characterization of extracellular circulating microRNA","volume":"39","author":"Turchinovich","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.aohep.2020.04.012_bib0560","doi-asserted-by":"crossref","first-page":"R125","DOI":"10.1093\/hmg\/dds317","article-title":"Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy","volume":"21","author":"Lee","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.aohep.2020.04.012_bib0565","doi-asserted-by":"crossref","first-page":"17644","DOI":"10.3390\/ijms151017644","article-title":"Circulating RNA molecules as biomarkers in liver disease","volume":"15","author":"Enache","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0570","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-306996","article-title":"Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis","author":"Pirola","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.04.012_bib0575","doi-asserted-by":"crossref","first-page":"3629","DOI":"10.2174\/0929867311320290009","article-title":"MicroRNA miR-122 as a therapeutic target for oligonucleotides and small molecules","volume":"20","author":"Thomas","year":"2013","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.aohep.2020.04.012_bib0580","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2011.09.001","article-title":"A feedback loop between the liver-enriched transcription factor network and Mir-122 controls hepatocyte differentiation","volume":"142","author":"Laudadio","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0585","doi-asserted-by":"crossref","first-page":"e0142661","DOI":"10.1371\/journal.pone.0142661","article-title":"Performance of serum microRNAs -122, -192 and -21 as biomarkers in patients with non-alcoholic steatohepatitis","volume":"10","author":"Becker","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.aohep.2020.04.012_bib0590","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2006.01.005","article-title":"miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting","author":"Esau","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.aohep.2020.04.012_bib0595","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nature04303","article-title":"Silencing of microRNAs in vivo with \u2018antagomirs\u2019","volume":"438","author":"Kr\u00fctzfeldt","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2020.04.012_bib0600","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1053\/j.gastro.2017.08.013","article-title":"Metabolic circuit involving free fatty acids, microRNA 122, and triglyceride synthesis in liver and muscle tissues","volume":"153","author":"Chai","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0605","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/hep.22569","article-title":"Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression","volume":"48","author":"Cheung","year":"2008","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0610","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/liv.13109","article-title":"Hepatic miR-33a\/miR-144 and their target gene ABCA1 are associated with steatohepatitis in morbidly obese subjects","volume":"36","author":"Vega-Badillo","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.04.012_bib0615","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.1073\/pnas.1102281108","article-title":"miR-33a\/b contribute to the regulation of fatty acid metabolism and insulin signaling","volume":"108","author":"Davalos","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.aohep.2020.04.012_bib0620","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/nature10486","article-title":"Inhibition of miR-33a\/b in non-human primates raises plasma HDL and lowers VLDL triglycerides","volume":"478","author":"Rayner","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.aohep.2020.04.012_bib0625","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cellsig.2013.09.018","article-title":"Profibrotic effect of miR-33a with Akt activation in hepatic stellate cells","volume":"26","author":"Li","year":"2014","journal-title":"Cell Signal"},{"key":"10.1016\/j.aohep.2020.04.012_bib0630","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1136\/gutjnl-2015-310044","article-title":"Emerging role of miR-21 in non-alcoholic fatty liver disease","volume":"65","author":"Benhamouche-Trouillet","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.04.012_bib0635","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.3390\/ijms16035161","article-title":"Potential epigenetic mechanism in non-alcoholic fatty liver disease","volume":"16","author":"Sun","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0640","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1136\/gutjnl-2014-308430","article-title":"MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway","volume":"65","author":"Wu","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.04.012_bib0645","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1136\/gutjnl-2015-310822","article-title":"Stress-activated miR-21\/miR-21* in hepatocytes promotes lipid and glucose metabolic disorders associated with high-fat diet consumption","volume":"65","author":"Calo","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.04.012_bib0650","doi-asserted-by":"crossref","first-page":"e2748","DOI":"10.1038\/cddis.2017.172","article-title":"miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice","volume":"8","author":"Rodrigues","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.aohep.2020.04.012_bib0655","doi-asserted-by":"crossref","first-page":"847","DOI":"10.3892\/ijmm.2015.2076","article-title":"miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR","volume":"35","author":"Sun","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.aohep.2020.04.012_bib0660","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1002\/mnfr.201200182","article-title":"Lycopene inhibits hepatic steatosis via microRNA-21-induced downregulation of fatty acid-binding protein 7 in mice fed a high-fat diet","volume":"56","author":"Ahn","year":"2012","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/j.aohep.2020.04.012_bib0665","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0670","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1136\/gutjnl-2014-308883","article-title":"Liver microRNA-21 is overexpressed in non-alcoholic steatohepatitis and contributes to the disease in experimental models by inhibiting PPAR\u03b1 expression","volume":"65","author":"Loyer","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.aohep.2020.04.012_bib0675","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.bbalip.2017.05.001","article-title":"Downregulation of miR-192 causes hepatic steatosis and lipid accumulation by inducing SREBF1: novel mechanism for bisphenol A-triggered non-alcoholic fatty liver disease","volume":"1862","author":"Lin","year":"2017","journal-title":"Biochim Biophys Acta \u2013 Mol Cell Biol Lipids"},{"key":"10.1016\/j.aohep.2020.04.012_bib0680","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s10528-019-09905-5","article-title":"Down-regulation of SIRT1 expression by mir-23b contributes to lipid accumulation in HepG2 cells","volume":"57","author":"Borji","year":"2019","journal-title":"Biochem Genet"},{"key":"10.1016\/j.aohep.2020.04.012_bib0685","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8515343","article-title":"miR-26a potentially contributes to the regulation of fatty acid and sterol metabolism in vitro human HepG2 cell model of nonalcoholic fatty liver disease","volume":"2018","author":"Ali","year":"2018","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.aohep.2020.04.012_bib0690","doi-asserted-by":"crossref","first-page":"7466","DOI":"10.1038\/ncomms8466","article-title":"A metabolic stress-inducible miR-34a-HNF4\u03b1 pathway regulates lipid and lipoprotein metabolism","volume":"6","author":"Xu","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.aohep.2020.04.012_bib0695","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12986-018-0323-6","article-title":"Amelioration of hepatic steatosis is associated with modulation of gut microbiota and suppression of hepatic miR-34a in Gynostemma pentaphylla (Thunb.) Makino treated mice","volume":"15","author":"Jia","year":"2018","journal-title":"Nutr Metab (Lond)"},{"key":"10.1016\/j.aohep.2020.04.012_bib0700","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.mce.2018.03.016","article-title":"MiR-451a attenuates free fatty acids\u2013mediated hepatocyte steatosis by targeting the thyroid hormone responsive spot 14 gene","volume":"474","author":"Zeng","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0705","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.metabol.2018.03.023","article-title":"A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet","volume":"85","author":"Zhang","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.aohep.2020.04.012_bib0710","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/1440-1681.12940","article-title":"Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease","volume":"45","author":"Lei","year":"2018","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0715","doi-asserted-by":"crossref","first-page":"5864","DOI":"10.1002\/jcb.26776","article-title":"MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease","volume":"119","author":"Xu","year":"2018","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.aohep.2020.04.012_bib0720","article-title":"MicroRNA-27a regulates hepatic lipid metabolism and alleviates NAFLD via repressing FAS and SCD1","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2020.04.012_bib0725","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1016\/j.bbadis.2017.09.020","article-title":"MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR","volume":"1863","author":"Nie","year":"2017","journal-title":"Biochim Biophys Acta \u2013 Mol Basis Dis"},{"key":"10.1016\/j.aohep.2020.04.012_bib0730","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2017.09.042","article-title":"MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1","volume":"493","author":"Wang","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.aohep.2020.04.012_bib0735","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2174\/2211536607666180531093302","article-title":"Serum miR-29a and miR-122 as potential biomarkers for non-alcoholic fatty liver disease (NAFLD)","volume":"7","author":"Jampoka","year":"2018","journal-title":"MicroRNA"},{"key":"10.1016\/j.aohep.2020.04.012_bib0740","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1128\/MCB.00016-13","article-title":"MicroRNA 33 regulates glucose metabolism","volume":"33","author":"Ram\u00edrez","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0745","doi-asserted-by":"crossref","DOI":"10.1111\/liv.14067","article-title":"MicroRNA-30b regulates insulin sensitivity by targeting SERCA2b in non-alcoholic fatty liver disease","author":"Dai","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.aohep.2020.04.012_bib0750","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.jhep.2012.08.008","article-title":"miR-34a\/SIRT1\/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease","volume":"58","author":"Castro","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0755","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1159\/000447917","article-title":"Decreased MiR-155 level in the peripheral blood of non-alcoholic fatty liver disease patients may serve as a biomarker and may influence LXR activity","volume":"39","author":"Wang","year":"2016","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.aohep.2020.04.012_bib0760","doi-asserted-by":"crossref","first-page":"e0129251","DOI":"10.1371\/journal.pone.0129251","article-title":"MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis","volume":"10","author":"Csak","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1016\/j.aohep.2020.04.012_bib0765","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-018-0153-7","article-title":"Role of miR-223 in the pathophysiology of liver diseases","volume":"50","author":"Ye","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.aohep.2020.04.012_bib0770","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cca.2013.05.021","article-title":"Associations between circulating microRNAs (miR-21, miR-34a, miR-122 and miR-451) and non-alcoholic fatty liver","volume":"424","author":"Yamada","year":"2013","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.aohep.2020.04.012_bib0775","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1172\/JCI63455","article-title":"MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis","volume":"122","author":"Tsai","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.aohep.2020.04.012_bib0780","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.24079","article-title":"RNA-binding protein AUF1 suppresses miR-122 biogenesis by down-regulating Dicer1 in hepatocellular carcinoma","volume":"9","author":"Wu","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.aohep.2020.04.012_bib0785","doi-asserted-by":"crossref","first-page":"e56272","DOI":"10.1371\/journal.pone.0056272","article-title":"microRNA-122 dependent binding of Ago2 protein to hepatitis C virus RNA is associated with enhanced RNA stability and translation stimulation","volume":"8","author":"Conrad","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.aohep.2020.04.012_bib0790","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jhep.2015.10.023","article-title":"Mopping up miRNA: an integrated HBV transcript disrupts liver homeostasis by sequestering miR-122","volume":"64","author":"Luna","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0795","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/hep.26604","article-title":"Free cholesterol accumulation in hepatic stellate cells: mechanism of liver fibrosis aggravation in nonalcoholic steatohepatitis in mice","volume":"59","author":"Tomita","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.aohep.2020.04.012_bib0800","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ajpath.2012.06.010","article-title":"Epigenetic regulation of miR-34a expression in alcoholic liver injury","volume":"181","author":"Meng","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.aohep.2020.04.012_bib0805","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3892\/mmr.2014.2846","article-title":"microRNA-34a and microRNA-34c promote the activation of human hepatic stellate cells by targeting peroxisome proliferator-activated receptor \u03b3","volume":"11","author":"Li","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.aohep.2020.04.012_bib0810","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biopha.2013.03.014","article-title":"MicroRNA-21 activates hepatic stellate cells via PTEN\/Akt signaling","volume":"67","author":"Wei","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.aohep.2020.04.012_bib0815","doi-asserted-by":"crossref","first-page":"11549","DOI":"10.1038\/srep11549","article-title":"Integrative miRNA and gene expression profiling analysis of human quiescent hepatic stellate cells","volume":"5","author":"Coll","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.aohep.2020.04.012_bib0820","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/cvr\/cvu184","article-title":"The microRNA-15 family inhibits the TGF\u03b2-pathway in the heart","volume":"104","author":"Tijsen","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.aohep.2020.04.012_bib0825","doi-asserted-by":"crossref","first-page":"3966","DOI":"10.3390\/ijms19123966","article-title":"miRNA signature in NAFLD: a turning point for a non-invasive diagnosis","volume":"19","author":"Dongiovanni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.aohep.2020.04.012_bib0830","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ebiom.2018.09.051","article-title":"Targeting hepatic miR-221\/222 for therapeutic intervention of nonalcoholic steatohepatitis in mice","volume":"37","author":"Jiang","year":"2018","journal-title":"EBioMedicine"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268120300533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:40:47Z","timestamp":1761648047000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268120300533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":83,"alternative-id":["S1665268120300533"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2020.04.012","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease and microRNAs expression, how it affects the development and progression of the disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2020.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100212"}}